IL2 and cancer: Human-cancer-cell-derived exosomes are also reported to have various immunosuppressive effects by suppressing interleukin 2 (IL)-dependent immune cell activation and causing the apoptosis of immune cells with NK activity by inducing cancer-specific cytotoxic T lymphocytes (CTL) through the amplification of regulatory T cells [86,87].